SMALL NON-CLEAVED FOLLICULAR CENTER CELL LYMPHOMA - CLINICOPATHOLOGIC COMPARISON OF BURKITT AND NON-BURKITT VARIANTS IN FINNISH MATERIAL

被引:5
作者
AINE, R [1 ]
机构
[1] UNIV CENT HOSP TAMPERE, DEPT PATHOL, SF-33520 TAMPERE, FINLAND
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 10期
关键词
D O I
10.1016/0277-5379(85)90012-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective clinical and histopathological analysis was made of patients with small non-cleaved-type malignant lymphoma according to the classification of Lukes-Collins. Nineteen cases were classified as the Burkitt type and 41 cases as the non-Burkitt type. The non-Burkitt type was more variable cytologically. A bimodal age distribution was seen in both subgroups. One half in both subtypes had an advanced disease (stage III-IV). Lymphadenopathy was slightly more common in the non-Burkitt type. No patient with non-Burkitt''s lymphoma had mediastinal involvement (P < 0.01). Liver and spleen were not involved by the tumor of the Burkitt type (P < 0.005). Gastrointestinal involvement was seen in both types without differences. No statistical differences between the overall survivals of these subtypes were observed.
引用
收藏
页码:1179 / +
页数:1
相关论文
共 34 条
[1]  
AINE R, 1982, ACTA PATH MICRO IM A, V90, P251
[2]  
AINE R, 1984, SCAND J HAEMATOL, V32, P475
[3]  
AINE R, PATHOL RES PRACT
[4]  
ALAVAIKKO M, 1982, ACTA PATH MICRO IM A, V90, P241
[5]   THE REPRODUCIBILITY OF THE LUKES-COLLINS CLASSIFICATION OF NON-HODGKINS LYMPHOMAS IN A RETROSPECTIVE RECLASSIFICATION [J].
APAJASARKKINEN, M ;
ALAVAIKKO, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06) :735-741
[6]   AMERICAN BURKITTS-LYMPHOMA - CLINICOPATHOLOGIC STUDY OF 30 CASES .1. CLINICAL FACTORS RELATING TO PROLONGED SURVIVAL [J].
ARSENEAU, JC ;
CANELLOS, GP ;
BANKS, PM ;
BERARD, CW ;
GRALNICK, HR ;
DEVITA, VT .
AMERICAN JOURNAL OF MEDICINE, 1975, 58 (03) :314-321
[7]  
BERARD C, 1969, B WORLD HEALTH ORGAN, V40, P601
[8]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[9]  
GROGAN TM, 1982, CANCER-AM CANCER SOC, V49, P1817, DOI 10.1002/1097-0142(19820501)49:9<1817::AID-CNCR2820490914>3.0.CO
[10]  
2-F